Boston Scientific To Pay $1.6B For Endo Urology Portfolio
Boston Scientific Corp. has agreed to drop $1.6 billion to buy American Medical Systems Inc.'s urology portfolio, including its men's health and prostate health businesses, from Dublin-based Endo International PLC, the...To view the full article, register now.
Already a subscriber? Click here to view full article